Thomas G Cohn, MD | |
166 19th Street South, Suite 100, Sartell, MN 56377-2154 | |
(320) 251-0609 | |
(320) 251-3806 |
Full Name | Thomas G Cohn |
---|---|
Gender | Male |
Speciality | Physical Medicine And Rehabilitation |
Experience | 40 Years |
Location | 166 19th Street South, Sartell, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245273390 | NPI | - | NPPES |
457430800 | Medicaid | MN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0014X | Pain Medicine - Interventional Pain Medicine | 42304 (Minnesota) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Medical Scanning Consultants Pa | 9032005376 | 75 |
News Archive
When general anesthesia is required for surgery or another procedure, a patient's care team must be ready for anything—especially the rare, life-threatening syndrome known as malignant hyperthermia.
Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, according to a new study by NYU Langone Medicine Center researchers. The study is published online this week in the journal Nature.
A gene crucial for brain and heart development may also be associated with sudden unexplained death in epilepsy (SUDEP), the most common cause of early mortality in epilepsy patients.
Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. Preliminary results of a Mayo Clinic - TGen collaborative study shows the testosterone receptor may be a potential target to attack in treating triple negative breast cancer (TNBC).
› Verified 5 days ago
Entity Name | Medical Scanning Consultants Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659348092 PECOS PAC ID: 9032005376 Enrollment ID: O20040224001139 |
News Archive
When general anesthesia is required for surgery or another procedure, a patient's care team must be ready for anything—especially the rare, life-threatening syndrome known as malignant hyperthermia.
Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, according to a new study by NYU Langone Medicine Center researchers. The study is published online this week in the journal Nature.
A gene crucial for brain and heart development may also be associated with sudden unexplained death in epilepsy (SUDEP), the most common cause of early mortality in epilepsy patients.
Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. Preliminary results of a Mayo Clinic - TGen collaborative study shows the testosterone receptor may be a potential target to attack in treating triple negative breast cancer (TNBC).
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Thomas G Cohn, MD Po Box 1450, Minneapolis, MN 55485-6035 Ph: (952) 542-8553 | Thomas G Cohn, MD 166 19th Street South, Suite 100, Sartell, MN 56377-2154 Ph: (320) 251-0609 |
News Archive
When general anesthesia is required for surgery or another procedure, a patient's care team must be ready for anything—especially the rare, life-threatening syndrome known as malignant hyperthermia.
Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, according to a new study by NYU Langone Medicine Center researchers. The study is published online this week in the journal Nature.
A gene crucial for brain and heart development may also be associated with sudden unexplained death in epilepsy (SUDEP), the most common cause of early mortality in epilepsy patients.
Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. Preliminary results of a Mayo Clinic - TGen collaborative study shows the testosterone receptor may be a potential target to attack in treating triple negative breast cancer (TNBC).
› Verified 5 days ago
Mr. Thomas Christopher Kowalkowski, D.O. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2301 Connecticut Avenue South, Sartell, MN 56377 Phone: 320-229-1500 Fax: 320-229-1505 | |
Dr. Sam M Elghor, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 804 23rd St S, Sartell, MN 56377 Phone: 320-230-7788 Fax: 320-230-7789 |